Immunopathology of Extracellular Vesicles in Macrophage and Glioma Cross-Talk

J Clin Med. 2023 May 12;12(10):3430. doi: 10.3390/jcm12103430.

Abstract

Glioblastomas (GBM) are a devastating disease with extremely poor clinical outcomes. Resident (microglia) and infiltrating macrophages are a substantial component of the tumor environment. In GBM and other cancers, tumor-derived extracellular vesicles (EVs) suppress macrophage inflammatory responses, impairing their ability to identify and phagocytose cancerous tissues. Furthermore, these macrophages then begin to produce EVs that support tumor growth and migration. This cross-talk between macrophages/microglia and gliomas is a significant contributor to GBM pathophysiology. Here, we review the mechanisms through which GBM-derived EVs impair macrophage function, how subsequent macrophage-derived EVs support tumor growth, and the current therapeutic approaches to target GBM/macrophage EV crosstalk.

Keywords: exosomes; extracellular vesicles; glioblastoma; macrophage; microglia.

Publication types

  • Review